ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,033Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 171

$517K Total Retail Price of All Prescriptions

Rank: 13 out of 171

403 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

12% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,582 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 657 639 1 6
SIMVASTATIN 506 484 2 1
LISINOPRIL 405 379 3 2
CITALOPRAM HBR 334 309 4 31
OMEPRAZOLE 319 317 5 4
HYDROCODONE-ACETAMINOPHEN 282 260 S3 6 3
ALENDRONATE SODIUM 247 225 7 39
FUROSEMIDE 216 207 8 8
HYDROCHLOROTHIAZIDE 210 200 9 18
METFORMIN HCL 200 184 10 19
DONEPEZIL HCL 199 199 11 20
ZOLPIDEM TARTRATE 184 173 12 33
EXELON 183 178 13 74
NAMENDA 182 175 14 34
SERTRALINE HCL 181 181 15 40
AMLODIPINE BESYLATE 174 158 16 5
METOPROLOL TARTRATE 150 150 17 13
POTASSIUM CHLORIDE 146 136 18 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 112 19 57
ATENOLOL 110 104 20 25
METOPROLOL SUCCINATE 107 104 21 17
LOSARTAN POTASSIUM 104 104 22 15
DIGOXIN 103 103 23 38
GABAPENTIN 99 90 24 10
WARFARIN SODIUM 99 99 24 16
ATORVASTATIN CALCIUM 95 95 26 14
ROPINIROLE HCL 94 94 27 79
CLOPIDOGREL 92 87 28 44
TAMSULOSIN HCL 92 86 28 12
LOVASTATIN 83 73 30 46
CRESTOR 83 70 30 26
FLUOXETINE HCL 77 73 32 86
QUETIAPINE FUMARATE 74 71 33 111
TRAMADOL HCL 72 72 34 42
MELOXICAM 68 65 35 66
LANTUS 64 64 36 98
SPIRIVA 63 54 37 23
PRAVASTATIN SODIUM 63 62 37 27
FLUTICASONE PROPIONATE 62 58 39 50
CARVEDILOL 61 61 40 11
OXYBUTYNIN CHLORIDE 61 61 40 124
AZITHROMYCIN 56 48 42 65
RANITIDINE HCL 53 53 43 54
TRAZODONE HCL 53 53 43 48
GLIMEPIRIDE 52 52 45 105
HUMALOG 51 51 46 116
OXYBUTYNIN CHLORIDE ER 50 37 47 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.